Health News Today, Nov 11: Stroke Drug, FDA Alert, Measles
In health news today, federal regulators cleared a first-in-class medication to help prevent repeat strokes while issuing urgent hospital safety alerts for vascular guidewires and breathing tubes. At the same time, national disease trackers showed U.S. measles cases reaching a 35-year high just as international health officials review the country's elimination status. Rounding out today's updates for adults aged 45 to 75, new neuroimaging and nutrition studies explored how lifetime estrogen patterns relate to brain blood vessel health after age 70 and why processed sugary foods differ from whole fruit in breast cancer risk.
FDA Clears First Factor XIa Inhibitor to Cut Second Stroke Risk
The U.S. Food and Drug Administration granted clearance to Bayer's Sunharbo (asundexian) 50 mg tablets, the first factor XIa inhibitor authorized in the United States to help lower recurrent stroke risk, according to an FDA press announcement covered November 10 by STAT News. The once-daily tablet is cleared for use alongside antiplatelet therapy in adults after a recent mild-to-moderate non-cardioembolic ischemic stroke—caused by a clot outside the heart—or a high-risk transient ischemic attack (TIA), often called a "mini-stroke." In the Phase 3 OCEANIC-STROKE trial of 12,327 adults enrolled within 72 hours of symptoms, adding Sunharbo cut ischemic stroke risk by 26% over 14.2 months compared with placebo. Overall major bleeding matched placebo, though bleeding rose during the first 90 days and in patients older than 75, with gastrointestinal bleeding and diarrhea reported more often. Sunharbo is not cleared for atrial fibrillation or moderate-to-severe liver impairment.
What it means for you: Survivors of a recent ischemic stroke or TIA face higher risk of a second event, and age or liver health can shape bleeding considerations after 75. Ask your neurologist, cardiologist, or pharmacist how your secondary stroke prevention plan works and report unusual bruising or digestive bleeding promptly.
FDA Flags Recalled Catheter Guidewires and Hospital Breathing Tubes
Federal device regulators posted two high-priority Early Alerts on November 10 instructing hospitals and clinics to remove specific vascular guidewires and mechanical ventilation breathing tubes over manufacturing defects. In the first FDA Early Alert, Arrow International (Teleflex) told facilities to quarantine certain coated spring wire guides and pressure-injectable catheter kits after finding the hydrophilic coating may swell unevenly in saline, clump, and detach into the bloodstream—raising the risk of polymer emboli, blood clots, tissue injury, or stroke. In a second FDA Early Alert, Intersurgical Inc. moved to pull affected lots of 22mm Smoothbore breathing tubes and systems after testing showed some soft connectors were bonded with too little tetrahydrofuran solvent, creating a risk that tubes could disconnect from ventilators and interrupt oxygen delivery. Neither company had reported serious injuries or deaths as of early November.
What it means for you: Both alerts involve clinical supplies used inside hospital intensive care units, operating rooms, and infusion clinics rather than home equipment. If you or a loved one have an upcoming inpatient procedure requiring catheter placement or breathing support, ask your care team how their facility verifies device recall checks.
Longer Estrogen Exposure Tied to Healthier Brain Vessels After 70
Older women who experienced a longer reproductive lifespan or used menopausal hormone therapy showed fewer signs of microscopic blood vessel damage in the brain, Medical News Today reported November 10 from a longitudinal neuroimaging study. Researchers followed 352 dementia-free Swedish women averaging age 70 in the Gothenburg H70-1944 Birth Cohort, including 205 who completed repeat brain MRI scans five years later. Participants had an average reproductive span—from first menstruation to menopause—of just over 37 years. Reaching menopause at an older age and having used menopausal hormone therapy were each linked to a lower burden of cerebral small vessel disease, including fewer tiny tissue cavities called lacunes and slower buildup of white matter hyperintensities over five years, alongside stronger global white matter integrity. Because women represent roughly two-thirds of dementia cases, researchers noted these vascular findings complement proven daily brain-connectivity habits past age 50.
What it means for you: Menopause timing and past hormone history are part of your broader vascular and brain-aging profile, alongside everyday factors like blood pressure, sleep, and physical activity. Discuss your personal cardiovascular and cognitive health history with your doctor or gynecologist before making any decisions about hormone-related care.
U.S. Measles Cases Hit 35-Year High as CDC Weighs Vaccine Strategy
Confirmed measles infections across the United States climbed to 5,182 cases as of November 9—surpassing 2025's full-year total of 2,289 cases and marking the highest national tally in 35 years, Healthline News reported from Centers for Disease Control and Prevention tracking. Spread across 47 jurisdictions, 96% of cases stem from 43 outbreaks, led by Pennsylvania with 1,505 cases and at least four CDC-confirmed deaths, followed by South Carolina (670 cases) and Utah (536 cases). Nationally, 562 patients have been hospitalized, and 96% of infections involve unvaccinated individuals or people with unknown status. With the Pan American Health Organization reviewing U.S. data this week to decide whether the country loses the measles-elimination status held since 2000, NBC News reported that CDC staffers and public health groups recently met to evaluate stronger vaccination outreach.
What it means for you: While adults born before 1957 are generally considered immune from childhood exposure, adults aged 45 to 69—especially those traveling, caring for grandchildren, or living with weakened immunity—may have gaps in older vaccination records. Ask your doctor or pharmacist whether checking your measles immunity or updating your vaccine record fits your household.
92,000-Woman Study Links High-Sugar Foods to Breast Cancer Risk
Eating more than two servings per week of processed high-sugar foods such as sweetened breakfast cereals and ice cream was tied to a 28% higher risk of developing breast cancer compared with eating them less than once a month, Medical News Today reported November 9. Published in the European Journal of Nutrition, the study analyzed food frequency questionnaires and health records from more than 92,000 women aged 40 to 69 in the Health Examinees-Gem (HEXA-G) cohort. Notably, although whole fruit accounted for the largest share of participants' overall sugar intake, eating fruit showed no association with higher breast cancer risk. Oncology and nutrition specialists explained that refined added sugars and ultra-processed starches can promote chronic inflammation and altered insulin and lipid metabolism, whereas whole fruit delivers natural sugars inside a protective matrix of fiber, vitamins, minerals, and polyphenols.
What it means for you: Occasional sweet treats can still fit into a balanced life after 45, but swapping daily sweetened cereals or desserts for whole fruit, oats, nuts, and fiber-rich foods supports steadier metabolic health. Talk with your doctor or a registered dietitian for nutrition guidance tailored to your breast and metabolic risk profile.
Sources
This roundup is for general information only and is not medical advice.
